ADORA3 and Stroke: The nucleoside appears to act through the A3AR, to which it binds in the μM range, because a selective A3AR antagonist propyl 6-ethyl-5-((ethylthio)carbonyl)-2-phenyl-4-propylnicotinate (MRS1523) diminished the benefit of reduced stroke lesions.